Lennart Hansson

Lennart is a Senior Advisor and has broad experience from leading positions in venture capital, and pharmaceutical development and business development in biotech and pharma companies such as KabiGen, AstraZeneca, Biovitrum, and as CEO of Arexis. 

Lennart headed the Life Science team at Industrifonden between 2008-2016. He has worked on >30 company boards and is the co-founder of two pharmaceutical start-ups. Other current assignments include Chairmain of the Board positions at Sixera Pharma, Ignitus, and Cinclus Pharma Holding, and board membership positions at InDex Pharmaceuticals Holdings (publ), and Medivir (publ). 

Lennart holds a PhD in Genetics from the University of Umeå